Zai Lab Limited (ZLAB)
(Delayed Data from NSDQ)
$15.91 USD
+0.17 (1.08%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $15.94 +0.03 (0.19%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Price, Consensus and EPS Surprise
ZLAB 15.91 +0.17(1.08%)
Will ZLAB be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for ZLAB based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ZLAB
What Makes Zai Lab Limited Unsponsored ADR (ZLAB) a New Buy Stock
Ultragenyx (RARE) Surges 10.3%: Is This an Indication of Further Gains?
ZLAB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Seagen's (SGEN) Late-Stage Cervical Cancer Study Meets Goals
Zai Lab (ZLAB) Up on Breakthrough Therapy Tag for Oncology Drug
Mirati (MRTX) Q1 Earnings & Revenues Beat Estimates, Stock Up
Other News for ZLAB
ClearBridge Global Growth Strategy Q1 2024 Portfolio Manager Commentary
Baron New Asia Fund Q1 2024 Shareholder Letter
Baron Emerging Markets Fund Q1 2024 Shareholder Letter
ClearBridge International Growth ACWI Ex-US Strategy Q1 2024 Commentary
Zai Lab files automatic ordinary shares offering